Ken Ebihara

Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway

Mitsuyo Shintani, Yoshihiro Ogawa, Ken Ebihara et al. · Diabetes · 2001 · 856 citations · Full text

Life Sciences, Endocrinology, Neuroscience +17

Pathophysiological role of leptin in obesity-related hypertension

Megumi Aizawa‐Abe, Yoshihiro Ogawa, Hiroaki Masuzaki et al. · Journal of Clinical Investigation · 2000 · 479 citations · Full text

Life Sciences, Endocrinology, Physiology +13

Serum leptin level is a regulator of bone mass

Florent Elefteriou, S. Takeda, Ken Ebihara et al. · Proceedings of the National Academy of Sciences · 2004 · 336 citations · Full text

Medicine, Endocrinology, Physiology +17

Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons

Takashige Kuwabara, Kiyoshi Mori, Masashi Mukoyama et al. · Kidney International · 2009 · 301 citations

Medicine, Nephrology, Pathology +15

Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes

Ken Ebihara, Yoshihiro Ogawa, Hiroaki Masuzaki et al. · Diabetes · 2001 · 242 citations · Full text

Medicine, Endocrinology, Molecular Biology +17